Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Today, Benzinga's options scanner identified 8 options transactions for DexCom. This is an unusual occurrence. The sentiment ...

Soliqua 100/33 (insulin glargine/lixisenatide ... For a detailed Soliqua 100/33 dosing chart, see the drug’s prescribing information. The chart lists possible doses up to the maximum dose ...

Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period ...

Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks ...

The Federal Communications Commission on Wednesday released the transcript of a “60 Minutes” interview with Vice President Kamala Harris that has been at the center of a lawsuit between CBS and ...

Williams is facing issues with its own fire-retardant product in its new downtown headquarters. We’re talking about what’s wrong with the building — and what the company isn’t saying — on Today in ...

The number of prescribing errors found on chart ... a quick price and instant permission to reuse the content in many different ways. Competing interests: M T Korytkowski has received the following ...

Cosmetic dentist Dr Namrata Jadwani, who co-founded Seven Oral Care, launched the luxury oral beauty brand with the idea of ...

Over the past decade, the rising cost of insulin epitomized the broader systemic issue of higher healthcare out-of-pocket ...

If California patients pay more than $35 per month for insulin now, it’s in large part because PBMs have rigged the system in ...

It’s now $17.16, a 56% drop. In other words, insulin manufacturers have been dropping their prices because of old-fashioned competition. And that’s largely solved the problem the proposed out ...